Glafenine
CAS No. 3820-67-5
Glafenine ( Glafenine; Glafenin; Glafenina )
Catalog No. M14324 CAS No. 3820-67-5
Glafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins..
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 32 | In Stock |
|
100MG | 45 | In Stock |
|
200MG | 61 | In Stock |
|
500MG | 133 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlafenine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins..
-
DescriptionGlafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins..
-
SynonymsGlafenine; Glafenin; Glafenina
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number3820-67-5
-
Formula Weight372.80
-
Molecular FormulaC19H17ClN2O4
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(OCC(O)CO)C1=CC=CC=C1NC2=CC=NC3=CC(Cl)=CC=C23
-
Chemical Name2,3-Dihydroxypropyl N-(7-chloro-4-quinolyl) anthranilate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kleinknecht D, et al. Clin Nephrol. 1986 Jun;25(6):275-8
molnova catalog
related products
-
FK 3311
FK 3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).
-
Polydatin
Polydatin, the glycoside of Resveratrol, is originally isolated from the Chinese herbPolygonum cuspidatum.
-
Etoricoxib
Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).